{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:45:19Z","timestamp":1759333519420},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1317,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1111\/j.1365-2133.2012.10802.x","type":"journal-article","created":{"date-parts":[[2012,1,23]],"date-time":"2012-01-23T14:10:31Z","timestamp":1327327831000},"page":"237-238","source":"Crossref","is-referenced-by-count":9,"title":["Hidradenitis suppurativa and immune dysregulation"],"prefix":"10.1093","volume":"166","author":[{"given":"G.B.E.","family":"Jemec","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,1,23]]},"reference":[{"key":"10.1111\/j.1365-2133.2012.10802.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1600-0625.2008.00712_1.x","article-title":"What causes hidradenitis suppurativa?","volume":"17","author":"Kurzen","year":"2008","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10802.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1517\/14656566.5.8.1767","article-title":"Medical treatment of hidradenitis suppurativa","volume":"5","author":"Jemec","year":"2004","journal-title":"Expert Opin Pharmacother"},{"key":"10.1111\/j.1365-2133.2012.10802.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00054725-200111000-00008","article-title":"Hidradenitis suppurativa and Crohn\u2019s disease: response to treatment with infliximab","volume":"7","author":"Mart\u00ednez","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/j.1365-2133.2012.10802.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2340\/00015555-0747","article-title":"Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors","volume":"89","author":"Haslund","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2133.2012.10802.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","article-title":"Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial","volume":"62","author":"Grant","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10802.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2133.2011.10339.x","article-title":"A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa","volume":"165","author":"Miller","year":"2011","journal-title":"Br J Dermatol"},{"issue":"2 Suppl. 1","key":"10.1111\/j.1365-2133.2012.10802.x-BIB7|cit7","article-title":"Efficacy and safety of adalimumab in treatment of moderate to severe hidradenitis suppurativa: results from the placebo-controlled portion of a phase II, randomized, double-blind study","volume":"64","author":"Kimball","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10802.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2340\/00015555-0749","article-title":"Increased serum tumour necrosis factor-alpha in hidradenitis suppurativa patients: is there a basis for treatment with anti-tumour necrosis factor-alpha agents?","volume":"89","author":"Matusiak","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2133.2012.10802.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1365-2133.2011.10254.x","article-title":"Elevated levels of tumour necrosis factor (TNF)-\u03b1, interleukin (IL)-1\u03b2 and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-\u03b1 and IL-1\u03b2","volume":"164","author":"van der Zee","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10802.x-BIB10|cit10","article-title":"Hidradenitis suppurativa: the role of deficient cutaneous innate immunity","author":"Dr\u00e9no","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10802.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2133.2011.10698.x","article-title":"Adalimumab (antitumour necrosis factor-\u03b1) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study","volume":"166","author":"van der Zee","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10802.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2133.2011.10459.x","article-title":"The aetiology of acne inversa: an evolving story","volume":"165","author":"Ingram","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10802.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000327928","article-title":"The concept of \u2018smokers\u2019 boils\u2019 is suggestive of a new hypothesis on the pathogenesis of hidradenitis suppurativa","volume":"222","author":"Jemec","year":"2011","journal-title":"Dermatology"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2012.10802.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2012.10802.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:54:39Z","timestamp":1676382879000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/166\/2\/237\/6613617"}},"subtitle":["Commentaries"],"short-title":[],"issued":{"date-parts":[[2012,1,23]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2012.10802.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1,23]]}}}